chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the first dose was on 03May2021 and the second, let me see, the second dose was on, that was on 20May2021; Arm swelled; Inflamed lymph nodes; Inflamed arm; I never had hematuria before, micro-hematuria and I am saying that this is the result of the Covid reaction to the Vaccine; tingling to my hand to my fingers and pain; tingling to my hand to my fingers and pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 20May2021 (Lot number: EW0177) at the age of 41 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (It looks like the first dose was on 03May2021 , Lot number: EW0173, Anatomical Site of administration: Consumer stated, It was on the left arm), administration date: 03May2021, when the patient was 41 years old, for COVID-19 immunization, reaction(s): "pain". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 20May2021, outcome "unknown", described as "the first dose was on 03May2021 and the second, let me see, the second dose was on, that was on 20May2021"; PERIPHERAL SWELLING (non-serious) with onset May2021, outcome "recovering", described as "Arm swelled"; LYMPHADENOPATHY (non-serious) with onset May2021, outcome "recovering", described as "Inflamed lymph nodes"; INFLAMMATION (non-serious) with onset May2021, outcome "recovering", described as "Inflamed arm"; HAEMATURIA (non-serious) with onset May2021, outcome "recovering", described as "I never had hematuria before, micro-hematuria and I am saying that this is the result of the Covid reaction to the Vaccine"; PARAESTHESIA (non-serious), PAIN (non-serious) all with onset May2021, outcome "recovering" and all described as "tingling to my hand to my fingers and pain". The events "arm swelled", "inflamed lymph nodes", "inflamed arm", "i never had hematuria before, micro-hematuria and i am saying that this is the result of the covid reaction to the vaccine", "tingling to my hand to my fingers and pain" and "tingling to my hand to my fingers and pain" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of peripheral swelling, lymphadenopathy, inflammation, haematuria, paraesthesia, pain.  No follow-up attempts are possible. No further information is expected.
Complains of arm swelling right arm at injection site, fever, chills, myalgia, headache.
I got the Pneumovax vaccine on Monday morning (8/9). I had the tight soreness at the injection site the next day, which is normal. However, I developed an elevated temperature by Friday evening. My temperature runs at a normal 97.6 but it had gotten up to 99.1.  As of this report (8/18), I still am struggling with temperature ups and down. My temp was up to 100.1 (as of last night). There are no other symptoms (such as stomach problems, headache, etc.)
Heart palpitations every day after the vaccine and lasting 2 and a half to 3 hours at a time. Every evening
This is a spontaneous case initially received from the physician on 07-Nov-2018, concerning a 03-year-old female child. The patient had no concomitant medications at the time of vaccination. On 06-Nov-2018, the patient (under age of 4 years) was administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252682 and expiry date: 30-Jun-2019) (explicitly coded as inappropriate age at vaccine administration). At the time of this report, no adverse event was reported. The reporter assessed this case as non-serious.
No adverse event; The vaccine was given 1 day past beyond use date of 23-Jun-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vaccine was given 1 day past beyond use date of 23-Jun-2022) and NO ADVERSE EVENT (No adverse event) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 24-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vaccine was given 1 day past beyond use date of 23-Jun-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vaccine was given 1 day past beyond use date of 23-Jun-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (The vaccine was given 1 day past beyond use date of 23-Jun-2022).    No concomitant medications were reported. It was reported that vaccine was given 1 day past beyond use date of 23-Jun-2022. The moderna was contacted and the lot was analyzed. It was stated that as per moderna this lot was still active and patient was not needed to be revaccinated. No treatment medications were reported.
Neuropathy; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age.  No information was provided regarding concomitant medications, concurrent conditions or medical history. On an unknown day in May 2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) by a physician as recommended for routine adult health maintenance for the prevention of shingles (dose, route, anatomical location, lot number and expiration date were not provided). On an unknown date, the patient experienced neuropathy.  As a direct and proximate result of the zoster Vaccine Live (ZOSTAVAX) vaccination, the patient's symptoms have resulted in physical limitations not present prior to using the zoster vaccine live (ZOSTAVAX). The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. In addition, the patient sustained severe and permanent personal injuries. The outcome of the events of neuropathy. The reporter considered the event to be related to zoster Vaccine Live (ZOSTAVAX).  Upon internal review, the event of neuropathy was determined to be medically significant. The events of neuropathy was considered to be disabling.
5/13/16-SORE ARM 7:00 PM PT TOOK IBUPROFEN. 5/14/2016- 10:00 PM ARM SWOLLEN 5/14/16- 3:00 PM ARM WENT LIMP WHILE DRIVING
noticed a single red blood blister on my right thumb following a hot bath 2 days after the injection. the blister began to fade two days after it appeared and is now gone.  Beginning this morning, 04/28/2021, I am experiencing an intermittent pain in the left lower leg, posterior medial aspect.
Information has been received from a registered nurse concerning a 6 year old white male with no allergies or medical history who on 11/2/98 at 11:00 AM was vaccinated SC in the left thigh with a first dose of varicella virus vaccine live (lot # 627333/1244H). There was no illness at the time of vaccination. On 7/25/04, the patient presented with a case of chicken pox. The patient had maculopapular lesions and some crusted lesions on the torso, face, upper extremities, and some in the mouth. He was treated with hydroxyzine hydrochloride and calamine (+) camphor (+) pramoxine hydrochloride. Subsequently, the patient recovered from chicken pox. A product quality complaint was not involved. Follow up information was received from a registered nurse who indicated that on 7/24/04, the patient had a rash all over his body. He was seen in the office on 7/25/04 with three different stages of lesions, red macules, red papules, crusted lesions, and new eruptions. He was diagnosed with varicella. Subsequently, the patient recovered. The patient had no adverse events following prior vaccination. No further information is expected.
Rash at injection site started about 48 hours after injection, about the size of a dime and then over the next 10 days, rash expanded to Nickle, quarter, solver dollar and then a large sand dollar. Continues to expand in size. No paid, full range of motion, a little itchy but tolerable.
Severe headache; body aches; fatigue; mild fever; chills; This is a spontaneous report from a contactable consumer. A 58 year old non pregnant female patient received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch Number: EL-3247), via unspecified route of administration in the left arm on 15Mar2021 at 02:30 PM (at the age of 58 years) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not included. The Patient was allergic to Morphine. The patient did not receive any other vaccine within 4 weeks prior to the vaccine.  On 15Mar2021 at 09:00PM, the patient experienced events severe headache, body aches, fatigue, mild fever and chills. The Clinical outcomes of events severe headache, body aches, fatigue, mild fever and chills were recovered on unknown dates. The patient had not tested positive for COVID-19 since the vaccination. No follow-up attempts are possible. No further information is expected.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. The patient's concurrent condition, medical history and concomitant medication were not reported. On an unknown date, the patient was inadvertently vaccinated with (recombinant Human albumin (rHA)) M-M-R II (lot # R028224, expiration date 02-OCT-2020, dose was unknown) intramuscularly for prophylaxis. No adverse effects. The outcome of the events was unknown. No product quality complaint (PQC) presented.
Pt reported that vaccine was given too high. He experienced severe shoulder pain and soreness for several days afterwards before seeking medical advise. He stated that he was not able to move his arm very well. His provider thought that it maybe had been injected into the cartilage and it was causing his increased soreness and shoulder pain. MRI was taken. He stated he is undergoing physical therapy to regain the use of his shoulder/arm and recently was prescribed a steroid and NSAID to help with this injury.
I have not gotten my period, which should have started April 9th (currently 20 days late). My breasts are extremely tender.
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 06-FEB-2019, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number R021055 with expiration date in 01-APR-2020) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001848: US-009507513-1907USA001849: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001825: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000989: US-009507513-1907USA000962: US-009507513-1907USA000988: US-009507513-1907USA000963: US-009507513-1907USA000953: US-009507513-1907USA000959: US-009507513-1907USA000968: US-009507513-1907USA000967: US-009507513-1907USA000964: US-009507513-1907USA000966: US-009507513-1907USA000954: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000965:
Noticed rash 6/9, getting progressively worse. Took to urgent care 6/10. Neck swollen and bright red 6/11.
Information has been received from a physician concerning a female adult patient who was vaccinated two doses of with VARIVAX (Merck) (dates, doses and lot # is not reported).  The patient had recent titers which were equivocal.  There were no adverse effects noted.  The patient had sought medical attention in the office.  Additional information has been requested.
I was administered my 3rd Anthrax injection and after a few days I started to get these little what looked like pimples on my right arm. They were there for a day or two. I had noticed they had popped and had this watery substance in them and the area started to itch pretty severely. This all was in Feb. 2001. This went on for a few months I notice it had moved to my hands and then to my upper thighs and calves and also my other arm. In May. 2001 I had gone to the doctor a couple of times and they had ruled out almost all skin rashes such as scabies, eczema, etc. I was referred to a dermatologist. I was given steroid shots and steroid pills for about 3 to 4 months and had they had no effect on my problem. In Aug 2001 I was referred to dermatology at hospital where they took a skin biopsy. They gave no diagnosis of the biopsy. I was seen then by other doctors and was told it might have been heat rash. Diagnosis went on for a year to 2 years. In Mid 2004 I was then referred to an allergist and was administer an allergy test where I had a variety of pricks on my back to see what kind of allergies I had. No diagnosis was given. In Dec. 2005 I PCSed and was seen at the dermatology here and a skin biopsy was taken and the results were the skin was severely inflamed and he prescribed a very strong topical cream named Cloetasol Propionate Cream. Once it was given to me it was the same thing I was given at my last base and it had no effect on my skin. So since Jan. 2001 I have had this skin rash starting out all over my arms and legs and neck to now its sporadic and break out when it wants to. My home remedy to get rid of the itch and pain is to run warm to hot water on the infected area for 5 to 10 minutes then dry it off and rub rubbing alcohol on it to really dry it out.
This spontaneous report as received from a health care worker refers to a patient of unknown demographics. It was reported that improperly stored GARDASIL may have been administered (dates unknown) for vaccination. No adverse events reported. Additional information is not expected.
Headache, Myalgia, chills, fatigue Narrative:  Headache, fatigue, chills, myalgia; taking Tylenol
given vaccines during improperly stored/temperature excursion; This spontaneous report as received from a licensed practical nurse referring to a 6-year-old patient of unknown age and gender. The patient's pertinent medical history, current condition, previous drug reaction or allergy, and concomitant medication were not reported.  02-NOV-2020, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter (strength, vaccination scheme, route of administration and anatomical site of vaccination were not reported, lot number T006345, expiration date reported and validated as 20-FEB-2022) for prophylaxis (Improper storage of product in use). The vaccine was exposed to the following temperature excursions: -13.9 degrees Celsius to 14.7 degrees Celsius; -14 degrees Celsius to -10 degrees Celsius, with an average of -13.9 degrees Celsius for 30 minutes. -14 degrees Celsius to -10 degrees Celsius, with an average of -14.2 degrees Celsius for 15 minutes; -14 degrees Celsius to -10 degrees Celsius, with an average of -14.7 degrees Celsius for 20 minutes and -14 degrees Celsius to -10 degrees Celsius, with an average of -14.6 degrees Celsius for 5 minutes as recorded by a data logger. There was no previous temperature excursion.; Sender's Comments:  US-009507513-2011USA001488:
Migraine - since first vaccine 28 days, nausea - started today 3/31/2021
No adverse events observed. Completing VAERS to document and incorrect dose administered. Child was administered 0.2 mL of undiluted COVID19 vaccine.
mild wheel and flare reaction at the site; Initial information received on 29-Sep-2020 regarding an unsolicited valid non-serious case from a physician.  This case is linked to case 2020SA272588 (same reporter).  This case involves a patient with an unknown demographic who experienced mild wheel and flare reaction at the site (vaccination site reaction), when received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's medical history, past medical treatment, past vaccination and family history were not provided.  Concomitant medication were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number and expiry date not reported) via an unknown route at an unknown administration site as prophylactic vaccination.  On an unknown date, the patient developed a non-serious mild wheel and flare reaction at the site (vaccination site reaction) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Laboratory details were not reported.  It was not reported if the patient received any corrective treatment.  The event outcome was unknown at the time of reporting.  There will be no information available on lot number for this case.
I had a red hard lump that hurt to the touch the 2nd and 3rd day but it went away.  Then on the 8th day the circular red area and a bigger lump (in diameter, not depth) appeared.  Not as sore to the touch.  That was yesterday and I still have it today.
Sudden collapse, medical examiner report shows: Cardiac dysrhythmia of unclear etiology follow by:  A: 19 year old male with sudden witnessed collapse B: Initial cardiac rhythm of ventricular tachycardia C: Cardiomyocyte hypertrophy and interstitial fibrosis (per cardiac pathology report) D: Molecular testing with a gene variant of uncertain significance II A: Inflammatory bowel disease
Patient received vaccines 7/26/11. Dtap, MMRV on Left thigh, IPV on (R) thigh. MMRV site, redness, cellulitis, pain occurring over 48 hour period. Area affected 3 cm x 3 cm on exam. Left anterior vastus lateralis. Patient started on antibiotic course.
1530: Patient complained of dizziness X 10 mins. Patient states that she has had episodes like this before when nervous or anxious. NP and EMT quickly assessed patient, and provided water. Vitals BP 108/75 HR 54 O2 99% RA.   1540: Second set of vitals 119/71, HR 71, O2 99%, BG 99  1600: Third set of vitals 130/88, HR 70, 02 99%. Patient stated she felt better and did not want any further medical intervention. Patient is with group of friends, and will be riding in an Uber back home.
Leukocytoclastic vasculitis began occurring in 8/21 and has continued to present. Presents as petechaie and purpura on the feet, legs, inner arms and stomach.
Information has been received from a physician via a literature article, concerning a female who on an unknown date was vaccinated with a dose of GARDASIL 0.5 ml, (dose number, lot#, application site and route were not reported). On an unknown date the patient had a premature birth. The Last Menstrual Period and Estimated Date of Delivery were unknown. The outcome of event was unknown. The investigator considered premature birth to be related to GARDASIL. Upon internal review premature birth was considered to be an other important medical event. Follow-up information was received in a published literature on 02-MAR-2015. This is one of the several reports from the same source. Additional information is not expected.
1ST. Issue-   Lactose Intolerance resulting in severe diarrhea within 24 hours after 1st.shot now treated with daily Lactase tablets  2ND Issue-   Extreme sunburn after 20 minute sun exposure to arms and legs (this happened on Monday 12th. April 2021)
patient presented with anxiety prior to receiving their injection.  Patient had a near syncopal episode within minutes of injection.  Pulse dropped into the 30's and was too weak to be felt by the treating nurse. EMS was activated at 1815 hours, who evaluated the patient.  Patient refused an IV, EMS ran a 4 lead, followed by a 12 lead.  After completing postural checks around 1840 hours the patient was advised by EMS recommending transport to the hospital.  Patient refused transport, and after EMS consulted via phone with medical direction the patient signed off on AMA with a plan to immediately head to Tacoma General hospital for follow up.
Seriousness criteria: other - medically significant.  This case was reported by a health professional on 05 October 2007.  A 37-year-old female patient, with an allergy to penicillin, received an intramuscular injection of Adacel on 10 September 2007.  The patient, who was also a physician, had received a tetanus vaccine (manufacturer and lot number unknown) in January 2007.  She was pregnant at the time of vaccination, and the date of her last menstrual period was 23 August 2007.  Obstetric history included two previous pregnancies with normal, full-term deliveries.  An ultrasound on 02 October 2007 confirmed the pregnancy, and estimated date of delivery was 29 May 2008.  Concomitant medication included prenatal vitamins.  The patient experienced no adverse reactions.  Follow-up information was received on 14 December 2007, case reference number 0711091401.  It was reported that an ultrasound on 26 October 2007 showed no fetal heartbeat.  The patient had a miscarriage.  No further information regarding the event or the outcome is available.  The patient's medical history included high blood pressure at the end of her first pregnancy, as well as post-partum thyroid dysfunction.  She had an upper respiratory infection/cold from 10 September 2007 to 17 September 2007 and again from 15 October 2007 to 15 October 2007.  She had exposure to alcohol (wine, eight to ten drinks total) in September 2007 and caffeine (coffee, one to two cups per day) during August 2007 and September 2007.  Based upon the new information regarding the event of miscarriage, this case has been upgraded to serious.